EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Airway Epithelial Barrier in Childhood Asthma: A Central Player in Glucocorticoid Therapy, Resistance, and Severe Asthma

Tangqiaochu Gan iD, Zhou Fu, Chao Niu iD

Pediatric Discovery · 2026-06 · 4 (2)

DOI: 10.1002/pdi3.70056 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Discovery, online erschienen am 26.05.2026. Verfasst von Tangqiaochu Gan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorde…. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Childhood asthma remains a global public health challenge with suboptimal control, despite the availability of inhaled corticosteroids (ICS) as first‐line therapy. Glucocorticoids suppress inflammation and protect the airway epithelial barrier (AEB) via genomic and nongenomic pathways. However, a significant subset of patients, particularly those with severe asthma, exhibits glucocorticoid resistance. Emerging evidence reveals a dual role of glucocorticoids on the AEB: beyond protection, they may inadvertently compromise barrier integrity by inducing epithelial apoptosis and dysfunction. This review synthesizes current knowledge on glucocorticoid mechanisms in asthma, focusing on the AEB as a critical interface between therapeutic efficacy and treatment failure. We show that AEB impairment serves as one of the key mechanisms underpinning glucocorticoid resistance and the progression to severe asthma, with heightened relevance in children due to the unique vulnerability of their developing airways. Furthermore, we examine how infections, nutritional factors (e.g., vitamins A and D), and immune maturation intersect with AEB integrity and glucocorticoid responsiveness. By reframing the AEB as both a target and a determinant of glucocorticoid efficacy, this review highlights the urgent need for barrier‐focused strategies to overcome resistance and improve outcomes in childhood asthma.

Schlagwörter

Stichwörter der Autor:innen

airway epithelial barrierasthmachildhood asthmaglucocorticoid resistanceglucocorticoidssevere asthma

Autor:innen und Institutionen

  • Department of Respiratory Medicine Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Diso…

ORCID-Profile: Tangqiaochu Gan, Chao Niu

Zitieren

APA

Gan, T., Fu, Z., & Niu, C. (2026). The Airway Epithelial Barrier in Childhood Asthma: A Central Player in Glucocorticoid Therapy, Resistance, and Severe Asthma. Pediatric Discovery, 4(2). https://doi.org/10.1002/pdi3.70056

Vancouver

Gan T, Fu Z, Niu C. The Airway Epithelial Barrier in Childhood Asthma: A Central Player in Glucocorticoid Therapy, Resistance, and Severe Asthma. Pediatric Discovery. 2026;4(2). doi:10.1002/pdi3.70056

BibTeX
@article{Gan2026,
  author = {Gan, Tangqiaochu and Fu, Zhou and Niu, Chao},
  title = {The Airway Epithelial Barrier in Childhood Asthma: A Central Player in Glucocorticoid Therapy, Resistance, and Severe Asthma},
  journal = {Pediatric Discovery},
  year = {2026},
  volume = {4},
  number = {2},
  doi = {10.1002/pdi3.70056}
}
Kostenlos starten →